MobiHealth News January 10, 2024
Its AI model can predict the accumulation of amyloid-beta protein, a major Alzheimer’s biomarker.
Japanese pharmaceutical company Eisai, together with Oita University in Japan, has built what could be the world’s first AI model that uses data from wearable devices to predict Alzheimer’s disease, the most common form of dementia.
Their research team embarked on a study to create a cost-effective, practical tool to pre-screen people suspected of developing the disease. Their findings were published in the journal Alzheimer’s Research & Therapy.
FINDINGS
The study collected biological and lifestyle data from 122 individuals aged 65 and older with mild cognitive impairment or subjective memory impairment. Biological data, including physical activity, sleep, and heart rate, were collected from wristband sensors they...
Today's Sponsors
Today's Sponsor